Use of vouchers and coupons offered by pharmaceutical companies to defray patients’ out-of-pocket drug costs is concentrated among a small number of drugs. While these
Read moreUniversity of Maryland School of Medicine (UMSOM) researchers have identified the most toxic proteins made by SARS-COV-2—the virus that causes COVID-19—and then used an FDA-approved
Read moreMore than five years after receiving an experimental immunotherapy drug, half of a group of people at high risk of developing Type 1 diabetes remained
Read moreA Hong Kong Baptist University-led (HKBU) research team has developed a novel drug which has the potential to become a next-generation treatment for cancers associated
Read moreA McMaster stem cell research team has made an important early step in developing a new class of therapeutics for patients with a deadly blood
Read moreA major clinical trial in Canada shows that an inexpensive anti-inflammatory drug called colchicine can significantly reduce the risk of complications and death from COVID-19,
Read moreU.S. regulators have approved the first long-acting drug combo for HIV, monthly shots that can replace the daily pills now used to control infection with
Read moreIf they’ve been listening to President Donald Trump, seniors may be expecting a $200 debit card in the mail any day now to help them
Read moreAdding the arthritis drug tocilizumab to standard care for patients in hospital with severe or critical COVID-19 is no better than standard care alone in
Read moreResearchers at the University of Gothenburg now suggest a possible cure for children with hard-to-treat forms of neuroblastoma using a new combination of drugs. In
Read more